News

In a press release announcing the move, Novo Nordisk cited market challenges and its declining share price in a press release ...
The CEO of Danish pharmaceutical giant Novo Nordisk, known for its blockbuster weight-loss drug Ozempic, will step down, the ...
Investors may get a second bite at the apple, and a second chance to buy this GLP-1 drug leader at a discount price.
"The Novo Nordisk Foundation is increasing its influence and has appointed its chairman, Lars Rebien Sørensen, as an observer ...